v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating Activities    
Net loss $ (26,661,677) $ (4,699,469)
Adjustments to reconcile net loss to net cash used in operating activities    
Stock-based compensation expense 3,462,633 0
Depreciation expense 8,553 759
Change in fair value of Simple Agreement for Future Equity liabilities 0 316,145
Changes in operating assets and liabilities    
Accounts payable and accrued expenses 621,756 1,419,814
Deposit liabilities 476,253 0
Other current liabilities 18,896 (93,584)
Deposit assets (597,011) 0
Deposit assets, long-term (1,360,004) 0
Prepaid expenses and other current assets (333,101) 0
Net cash used in operating activities (24,363,702) (3,056,335)
Investing Activities    
Purchases of equipment (439,223) (2,683)
Net cash used in investing activities (439,223) (2,683)
Financing Activities    
Proceeds from issuance of Simple Agreements for Future Equity 29,660,667 899,999
Proceeds from exercise of warrants 2,332 0
Proceeds from issuance of preferred stock and warrants 19,999,980 6,029,987
Issuance costs related to preferred stock (105,393) (83,486)
Payment of offering costs (3,519,309) 0
Net cash provided by financing activities 46,038,277 6,846,500
Increase in cash and cash equivalents 21,235,352 3,787,482
Cash and cash equivalents, at beginning of period 4,018,226 230,744
Cash and cash equivalents, at end of period 25,253,578 4,018,226
Supplemental disclosures of non-cash activities:    
Conversions of Simple Agreements for Future Equity to preferred stock 0 1,558,143
Offering costs included in accrued expenses $ 468,592 $ 0